
BB Biotech Ventures
Europe, Zurich, Switzerland, Zürich
Description
BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices.
Investor Profile
BB Biotech Ventures has backed more than 48 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 10% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series C (23%)
- Series A (19%)
- Series B (19%)
- Series Unknown (13%)
- Series D (10%)
- Post Ipo Equity (6%)
- Series E (4%)
- Private Equity (4%)
- Series G (2%)
Country Focus
- United States (56%)
- Switzerland (23%)
- The Netherlands (6%)
- Germany (6%)
- Ireland (4%)
- Italy (4%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Health Diagnostics
- Medical Device
- Therapeutics
- Biopharma
- Women's
- Neuroscience
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does BB Biotech Ventures frequently co-invest with?
What are some of recent deals done by BB Biotech Ventures?
Find More Investors Like BB Biotech Ventures
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









